Kingsview Wealth Management LLC Has $391,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Kingsview Wealth Management LLC raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 3,962 shares of the exchange traded fund’s stock after buying an additional 299 shares during the quarter. Kingsview Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $391,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Clal Insurance Enterprises Holdings Ltd acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $141,284,000. Affinity Asset Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 105.4% during the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after buying an additional 737,550 shares in the last quarter. Mirae Asset Securities USA Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth $55,626,000. Assetmark Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares in the last quarter. Finally, Sivik Global Healthcare LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $29,640,000.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $100.00 on Friday. SPDR S&P Biotech ETF has a 52 week low of $72.10 and a 52 week high of $105.47. The stock has a market capitalization of $7.62 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock has a fifty day moving average of $98.31 and a 200-day moving average of $96.48.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.